Medicare Enrolled

Dr. Richard Harkaway, M.D.

Urology Physician · Phila, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9880 BUSTLETON AVE, Phila, PA 19115
2156770667
In practice since 2005 (20 years)
NPI: 1700863529 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Harkaway from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harkaway? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Harkaway

Dr. Richard Harkaway is an urology physician in Phila, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Harkaway performed 3,338 Medicare services across 1,856 unique beneficiaries.

Between the years covered by Open Payments, Dr. Harkaway received a total of $14,191 from 51 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Harkaway is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 19% volume in PA $14,191 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,338
Medicare services
Top 19% in PA for urology physician
1,856
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~167 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
786 $8 $67
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
714 $3 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
639 $95 $342
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
415 $68 $243
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
241 $8 $12
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
113 $10 $115
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
111 $46 $169
Ultrasound of abdomen and pelvis blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis.
72 $111 $457
Limited abdominal ultrasound
A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures.
69 $69 $245
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
60 $124 $448
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
27 $110 $386
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
24 $57 $181
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
22 $146 $519
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
16 $208 $679
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $83 $302
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
14 $670 $2,235
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,191
Total received (2018-2024)
Avg $2,027/year across 7 years
Top 10% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,936 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$255 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,990
2023
$3,395
2022
$3,393
2021
$2,683
2020
$700
2019
$397
2018
$632

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,316
Sumitomo Pharma America, Inc.
$400
Teleflex LLC
$254
Dendreon Pharmaceuticals LLC
$216
Tolmar, Inc.
$152
Boston Scientific Corporation
$136
Photocure Inc
$125
Astellas Pharma US Inc
$72
PROGENICS PHARMACEUTICALS, INC.
$57
Janssen Biotech, Inc.
$52
ABBVIE INC.
$44
COLOPLAST CORP
$33
Cycle Pharmaceuticals Inc
$32
Tempus AI, Inc
$31
VERTEX PHARMACEUTICALS INCORPORATED
$30
UROGEN PHARMA, INC.
$26
PFIZER INC.
$15
Top 3 companies account for 65.9% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$4,347
Teleflex LLC
$1,768
Astellas Pharma US Inc
$1,178
Sumitomo Pharma America, Inc.
$1,041
Myovant Sciences Inc.
$834
Janssen Biotech, Inc.
$479
Dendreon Pharmaceuticals LLC
$458
Coloplast Corp
$456
Boston Scientific Corporation
$394
Amgen Inc.
$374
UROVANT SCIENCES INC
$234
Myriad Genetic Laboratories, Inc.
$220
PROCEPT BioRobotics Corporation
$206
AstraZeneca Pharmaceuticals LP
$175
ABBVIE INC.
$169
Tolmar, Inc.
$152
UroGen Pharma, Inc.
$147
Photocure Inc
$125
Ferring Pharmaceuticals Inc.
$115
Medtronic USA, Inc.
$96
Calyxo, Inc.
$96
AbbVie, Inc.
$88
Bayer HealthCare Pharmaceuticals Inc.
$82
PFIZER INC.
$67
Antares Pharma, Inc.
$60
Rigicon,Inc.
$60
AbbVie Inc.
$60
PROGENICS PHARMACEUTICALS, INC.
$57
SUN PHARMACEUTICAL INDUSTRIES INC.
$53
Merck Sharp & Dohme LLC
$52
Aytu BioScience, Inc
$51
Endo Pharmaceuticals Inc.
$47
Merck Sharp & Dohme Corporation
$47
COLOPLAST CORP
$33
Cycle Pharmaceuticals Inc
$32
Tempus AI, Inc
$31
VERTEX PHARMACEUTICALS INCORPORATED
$30
Retrophin, Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
UROGEN PHARMA, INC.
$26
GENZYME CORPORATION
$25
Novartis Pharmaceuticals Corporation
$21
BOSTON SCIENTIFIC CORPORATION
$20
Accord Healthcare, Inc.
$19
Telix Pharmaceuticals
$18
Acerus Pharmaceuticals Corporation
$18
DENTSPLY IH AB
$17
Verity Pharmaceuticals Inc.
$17
Rochester Medical Corporation
$15
CONMED Corporation
$15
Progenics Pharmaceuticals, Inc.
$14
Top 3 companies account for 51.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AIRSEAL · AMS 700 · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · BOTOX · Balversa · CAMCEVI · CVAC · CYSVIEW · ELIGARD · ERLEADA · EVENITY · FIRMAGON · GEMTESA · GENERAL BPH · ILLUCCIX · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Rigi10 Malleable Penile Prosthesis · SpaceOAR VUE System - 10mL · TITAN · Tiopronin · Titan · Trelstar · UROLIFT · UroLift System · XGEVA · XIAFLEX · XT CDX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for urology physician in PA.

Looking for an urology physician in Phila?
Compare urology physicians in the Phila area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
321
Per 100K population
20.3
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Harkaway is a clinical cardiology specialist, with above-average Medicare volume (top 19% in PA), with low-engagement industry engagement in the top 10% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Harkaway experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Harkaway performed 786 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harkaway receive payments from pharmaceutical companies?
Yes. Dr. Harkaway received a total of $14,191 from 51 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harkaway's costs compare to other urology physicians in Phila?
Dr. Harkaway's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harkaway) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →